Clinical Trials Browser

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT00963092 2013-08-12

Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer

Unknown

4,000 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00070278 2013-08-07

Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

Phase 3 Unknown

800 enrolled

Breast

Breast Neoplasms

NCT00897065 2013-07-10

Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17

Unknown

957 enrolled

Breast

Breast Neoplasms

NCT01421862 2013-07-10

Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment

Unknown

400 enrolled

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT01653613 2013-07-10

Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia

Unknown

400 enrolled

Other hematologic neoplasm

Leukemia

NCT00357617 2010-12-24

Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery

Phase 1/2 Unknown

24 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01119573 2010-06-22

Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer

Unknown

100 enrolled

Gynecologic

Endometrial Neoplasms

Clinical Trials

Study of Biomarkers in Tissue Samples From Patients With Breast Cancer

Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28

Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer

Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer

Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer

Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX

Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer

Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17

Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment

Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia

Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery

Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer